Significant organizational changes are necessary in order to embrace a model-based drug-development approach. The development pathway of new drugs seems to be disruptive, with little communication ...
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...
To have any impact, patient engagement needs to start with the drug development pathway, not at the point of licensing. That’s especially true in the rare disease space, where the unmet need is ...
Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...
Experts say A.I. is transforming the industry. Traditionally, drug development is expensive - often taking billions of dollars and years of experimentation and trials. And there is no guarantee ...
Precise calculations of binding free energy are pivotal in reducing the high costs and inefficiencies of drug discovery. A ...
A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers ...
independent team of Australian scientists won a rare approval – upending the normal drug development pathway. The success of their audacious strategy paves the way for charities and not-for ...
Extending their collaboration, Genialis and Debiopharm continue working towards a patient classifier to support WEE1 clinical development ... landscape of cancer drug targets, including DDR.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback